ロード中...
Treatment of genotype 2 and 3 chronic hepatitis C virus-infected patients
AIM: Before pegylated interferon alpha (IFN) was introduced for the therapy of chronic hepatitis C virus (HCV)-induced hepatitis, conventional thrice weekly IFN therapy was supplemented by ribavirin. Also, at that time, higher and more frequent doses of IFN were expected to be more effective than th...
保存先:
| 出版年: | World J Gastroenterol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2005
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4436638/ https://ncbi.nlm.nih.gov/pubmed/16273648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v11.i39.6188 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|